A 19-year-old medical student is admitted with acute bacterial meningitis. CSF analysis shows pleocytosis with predominant neutrophils, low glucose, and elevated protein. Gram stain of CSF reveals gram-negative diplococci. Blood culture and CSF culture are pending. What is the most appropriate empiric antibiotic regimen for suspected meningococcal meningitis in this patient?

Explanation

## First-Line Treatment for Meningococcal Meningitis **Key Point:** Ceftriaxone 2 g IV every 6 hours (or cefotaxime 2 g IV every 4 hours) is the gold-standard first-line empiric therapy for bacterial meningitis caused by N. meningitidis, recommended by all major guidelines including WHO, CDC, and Indian protocols. ### Why Cephalosporin for Meningitis? **High-Yield:** Third-generation cephalosporins are preferred for meningitis because: 1. **Superior CNS penetration**: Achieve CSF concentrations of 10–20% of serum levels (adequate for meningitis) 2. **Efficacy against meningococci**: >99% bactericidal activity against susceptible and intermediate-resistant strains 3. **Resistance coverage**: Effective against penicillin-resistant N. meningitidis (PRNM), which is emerging globally 4. **Rapid CSF sterilization**: Faster CSF sterilization compared to penicillin ### Dosing for Meningitis (Higher Than Non-Meningitis Infections) | Drug | Meningitis Dose | Non-Meningitis Dose | Reason | |------|-----------------|--------------------|---------| | Ceftriaxone | 2 g IV Q6H | 1–2 g IV Q12H | Higher CSF penetration required | | Cefotaxime | 2 g IV Q4H | 1–2 g IV Q6–8H | Shorter half-life; frequent dosing needed | | Penicillin G | 4 MU IV Q4H (meningitis) | 2–4 MU IV Q4–6H | Suboptimal CSF penetration; resistance emerging | **Clinical Pearl:** The CSF penetration of cephalosporins is enhanced by meningeal inflammation; as inflammation resolves, CSF levels may drop—this is why high-dose, frequent dosing is essential. ### Why Other Options Are Suboptimal or Obsolete **Penicillin G (Option 1):** - ~~Once the gold standard~~ — now obsolete for meningitis - Penicillin-resistant N. meningitidis (PRNM) prevalence is rising globally - CSF penetration is lower than cephalosporins - Not recommended as monotherapy in modern guidelines **Chloramphenicol (Option 2):** - Excellent CSF penetration historically - Now obsolete due to: - Rare but fatal aplastic anemia risk - Availability issues in many countries - Inferior outcomes compared to cephalosporins - No longer recommended by any major guideline **Vancomycin (Option 3):** - **Not first-line monotherapy** - Reserved for: - Penicillin-resistant strains (MIC ≥0.1 μg/mL) - Cephalosporin allergy (non-IgE mediated) - Combination with cephalosporin in high-risk scenarios - Slower CSF penetration than cephalosporins - Requires therapeutic drug monitoring **Mnemonic:** **"CEFT for MENINGITIS"** — Cephalosporin (3rd-gen) is the empiric choice for bacterial meningitis; Penicillin is now second-line due to emerging resistance. ### Current Indian Guidelines Indian STI and meningitis management protocols (NACO, AIIMS, ICMR) recommend ceftriaxone or cefotaxime as first-line for meningococcal meningitis.